AU2003264319A1 - New tumor antigen vaccine and producing method and vaccine composition - Google Patents

New tumor antigen vaccine and producing method and vaccine composition

Info

Publication number
AU2003264319A1
AU2003264319A1 AU2003264319A AU2003264319A AU2003264319A1 AU 2003264319 A1 AU2003264319 A1 AU 2003264319A1 AU 2003264319 A AU2003264319 A AU 2003264319A AU 2003264319 A AU2003264319 A AU 2003264319A AU 2003264319 A1 AU2003264319 A1 AU 2003264319A1
Authority
AU
Australia
Prior art keywords
vaccine
tumor antigen
producing method
new tumor
vaccine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003264319A
Inventor
Jin Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003264319A1 publication Critical patent/AU2003264319A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2003264319A 2002-09-13 2003-09-15 New tumor antigen vaccine and producing method and vaccine composition Abandoned AU2003264319A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB021369658A CN1315536C (en) 2002-09-13 2002-09-13 Novel vaccine of tumor antigen, its preparation method and vaccine composition
CN02136965.8 2002-09-13
PCT/CN2003/000776 WO2004024181A1 (en) 2002-09-13 2003-09-15 New tumor antigen vaccine and producing method and vaccine composition

Publications (1)

Publication Number Publication Date
AU2003264319A1 true AU2003264319A1 (en) 2004-04-30

Family

ID=31983684

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003264319A Abandoned AU2003264319A1 (en) 2002-09-13 2003-09-15 New tumor antigen vaccine and producing method and vaccine composition

Country Status (3)

Country Link
CN (1) CN1315536C (en)
AU (1) AU2003264319A1 (en)
WO (1) WO2004024181A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101999376B1 (en) * 2006-07-28 2019-07-11 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Improved vaccines and methods for using the same
CN101724011B (en) * 2008-10-21 2011-11-23 南京瑞尔医药有限公司 Preparation method and application of tumor tissue complete antigen
CN102973950B (en) * 2011-09-06 2015-05-27 四川百利药业有限责任公司 PRAME and WT1 bivalent tumor DNA vaccine
CN104800838B (en) * 2015-04-14 2018-01-09 深圳市中联生物科技开发有限公司 MUC1 Fc polypeptide vaccines and its preparation method and application
WO2017125844A1 (en) * 2016-01-19 2017-07-27 Pfizer Inc. Cancer vaccines
CN111150841B (en) * 2019-12-31 2023-08-15 优锐生物医药科技(深圳)有限公司 Active immune regulation particle and preparation method and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432714A1 (en) * 1984-09-06 1986-04-24 Behringwerke Ag, 3550 Marburg TUMOR THERAPEUTICS AND METHOD FOR THE PRODUCTION THEREOF
UY24367A1 (en) * 1995-11-23 2000-10-31 Boehringer Ingelheim Int TUMOR VACCINES AND PRODUCTION PROCEDURE
DK1187918T4 (en) * 1999-06-07 2009-02-23 Immunex Corp Tek antagonists
AU6064400A (en) * 1999-07-02 2001-01-22 Genentech Inc. Fusion peptides comprising a peptide ligand domain and a multimerization domain
SK782002A3 (en) * 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
US6825848B1 (en) * 1999-09-17 2004-11-30 S3 Graphics Co., Ltd. Synchronized two-level graphics processing cache
CN1142183C (en) * 2001-08-23 2004-03-17 北京大学人民医院 Anti-idiotype microantibody and its preparing process and application
CN1442482A (en) * 2002-03-06 2003-09-17 余晓红 Carrier and method of enhancing gene immune effect and its application in immunology

Also Published As

Publication number Publication date
CN1315536C (en) 2007-05-16
WO2004024181A1 (en) 2004-03-25
CN1481899A (en) 2004-03-17

Similar Documents

Publication Publication Date Title
AU2003248563A1 (en) Method of forming nanocrystals
PT1361893E (en) Modified anti-egfr antibodies with reduced immunogenicity
ZA200604957B (en) Immunogenic peptide carrier conjugates and methods of producing same
HUP0401753A3 (en) Antigen presenting cells, method for their preparation and their use for cancer vaccines
AU2003240233A1 (en) Method and arrangement for producing radiation
AU2003221704A1 (en) Immunogenic peptides, and method of identifying same
HUP0600145A2 (en) Shoe and method for producing thereof
AU2003256912A1 (en) Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
AU2003230253A1 (en) Luminous tile and preparing method thereof
AU2003213718A1 (en) Method of producing antigens
AU2003210151A1 (en) Silicon-containing magnetic particles, method for producing said particles and use of the same
AU2002349543A1 (en) Tumor antigens
AU2003289603A1 (en) Tumor vaccine
AU2003278175A1 (en) Vaccines of enhanced immunogenicity, and methods for preparing such vaccines
AU2003264319A1 (en) New tumor antigen vaccine and producing method and vaccine composition
EP1607462A4 (en) Phosphor and method for producing same
AU2003241938A1 (en) Artificial gem and its producing method
AU2002246950A1 (en) Hydrocapsules and method of preparation
AU2003276844A1 (en) Formulations of modified antibodies and methods of making the same
AU2002953238A0 (en) In vitro immunization
AU2003268180A1 (en) Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
AU2003263962A1 (en) Tissue compositions and methods for producing same
AU2003211508A1 (en) Envelope and method of producing the same
AU2002340850A1 (en) Antigen mimotopes and vaccine against cancers
AU2003210719A1 (en) Identification of mutant antigens with enhanced immunogenicity

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase